Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML
Condition(s):Acute Myeloid LeukemiaLast Updated:August 22, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Acute Myeloid LeukemiaLast Updated:August 22, 2018Completed
Condition(s):Acute Myeloid LeukemiaLast Updated:August 2, 2016Terminated
Condition(s):Mantle Cell LymphomaLast Updated:March 20, 2023Completed
Condition(s):Acute LeukemiaLast Updated:February 9, 2021Unknown status
Condition(s):AMLLast Updated:October 5, 2023Recruiting
Condition(s):Acute Myeloid Leukemia, Relapsed, AdultLast Updated:October 10, 2023Terminated
Condition(s):Acute Myeloid LeukemiaLast Updated:February 20, 2024Active, not recruiting
Condition(s):Leukemia, Myeloid, AcuteLast Updated:January 11, 2022Terminated
Condition(s):Acute Myeloid Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeLast Updated:January 10, 2024Active, not recruiting
Condition(s):High-risk (Secondary) Acute Myeloid LeukemiaLast Updated:December 28, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.